A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Diabetes Complications
Disease Management
Female
Humans
India
/ epidemiology
Infant
Male
Middle Aged
Molecular Diagnostic Techniques
Mucorales
/ classification
Mucormycosis
/ diagnosis
Prospective Studies
Risk Factors
Survival Analysis
Tertiary Care Centers
Treatment Outcome
Wounds and Injuries
/ complications
Young Adult
Rhizopus arrhizus
Rhizopus homothallicus
diagnosis
epidemiology
mucormycosis
therapy
Journal
Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835
Informations de publication
Date de publication:
01 Jun 2019
01 Jun 2019
Historique:
received:
05
04
2018
revised:
21
06
2018
accepted:
12
07
2018
pubmed:
8
8
2018
medline:
30
4
2019
entrez:
8
8
2018
Statut:
ppublish
Résumé
Mucormycosis due to Mucorales is reported at large numbers in uncontrolled diabetics across India, but systematic multicenter epidemiological study has not been published yet. The present prospective study was conducted at four major tertiary care centers of India (two in north and two in south India) during 2013-2015 to compare the epidemiology, treatment strategies and outcome of mucormycosis between the two regions. Molecular techniques were employed to confirm the identity of the isolates or to identify the agent in biopsy samples. A total of 388 proven/probable mucormycosis cases were reported during the study period with overall mortality at 46.7%. Uncontrolled diabetes (n = 172, 56.8%) and trauma (n = 31, 10.2%) were the common risk factors. Overall, Rhizopus arrhizus (n = 124, 51.9%) was the predominant agent identified, followed by Rhizopus microsporus (n = 30, 12.6%), Apophysomyces variabilis (n = 22, 9.2%) and Rhizopus homothallicus (n = 6, 2.5%). On multivariate analysis, the mortality was significantly associated with gastrointestinal (OR: 18.70, P = .005) and pulmonary infections (OR: 3.03, P = .015). While comparing the two regions, majority (82.7%) cases were recorded from north India; uncontrolled diabetes (n = 157, P = .0001) and post-tubercular mucormycosis (n = 21, P = .006) were significantly associated with north Indian cases. No significant difference was noted among the species of Mucorales identified and treatment strategies between the two regions. The mortality rate was significantly higher in north Indian patients (50.5%) compared to 32.1% in south India (P = .016). The study highlights higher number of mucormycosis cases in uncontrolled diabetics of north India and emergence of R. microsporus and R. homothallicus across India causing the disease.
Identifiants
pubmed: 30085158
pii: 5063412
doi: 10.1093/mmy/myy060
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
395-402Informations de copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.